GATA1 Expression in BCR/ABL1 -negative Myeloproliferative Neoplasms
2018; 38(4): 296-305
Korean J Lab Med 2010; 30(2): 122-125
Published online April 1, 2010 https://doi.org/10.3343/kjlm.2010.30.2.122
Copyright © Korean Society for Laboratory Medicine.
Kyo Kwan Lee, M.D.1, Han-Ik Cho, M.D.2, Hyun-Sook Chi, M.D.3, Do Yeun Kim, M.D.4, Seok-Lae Chae, M.D.1, and Hee Jin Huh, M.D.1
Departments of Laboratory Medicine1 and Internal Medicine4, Dongguk University Ilsan Hospital, Goyang; Department of Laboratory Medicine2, Seoul National University Bundang Hospital, Seongnam; Department of Laboratory Medicine3, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea
Correspondence to: Hee Jin Huh, M.D.
Department of Laboratory Medicine, Dongguk University Ilsan Hospital, 814 Siksa-dong, Ilsandong-gu, Goyang 410-773, Korea
Tel : +82-31-961-7893, Fax : +82-31-961-7902
E-mail : hjhuh@duih.org
Essential thrombocythemia (ET) is a chronic myeloproliferative neoplasm that involves primarily the megakaryocytic lineage. After many years, a few patients with ET may develop bone marrow (BM) fibrosis and rarely develop osteosclerosis. A 60-yr-old female was admitted due to severe left upper quadrant abdominal discomfort. She had been diagnosed as ET 19 yrs ago. On liver computed tomography severe splenomegaly was shown. Laboratory tests revealed WBC 24.3×109/L, hemoglobin 13.4 g/dL, platelets 432×109/L, lactate dehydrogenase 4,065 IU/L (reference range; 240-480). Blood smear demonstrated leukoerythroblastosis, teardrop cells, and giant and hypogranular platelets. BM study revealed inadequate aspirate due to dry tap. BM biopsy showed clusters of dysplastic megakaryocytes, grade 3 fibrosis, and severe osteosclerosis. Major/minor BCR-ABL1 rearrangement and JAK2 V617F mutation were not detected. Cytogenetic studies revealed normal karyotype. According to the 2008 WHO diagnostic criteria, the patient was diagnosed as having post-essential thrombocythemia myelofibrosis with severe osteosclerosis.
Keywords: Essential thrombocythemia, Myelofibrosis, Osteosclerosis